We report a case of imported dengue hemorrhagic fever (DHF) in a 10-year-old Philippine boy. The patient was admitted to the hospital with a 4-day history of high fever, headache, and malaise, and a 2-day history of epistaxis and hematemesis.
| INTRODUCTION
Dengue hemorrhagic fever (DHF), which occurs secondary to dengue fever, is characterized by hemorrhagic manifestations and progressive effusions. Although dengue fever is typically a self-limiting disease with a mortality rate of <1%, DHF is a severe, potentially deadly disease. 1 As DHF occurs more frequently among cases of reinfection than among cases of primary infection, 2 DHF seldom occurs in nonendemic areas. Reporting of infectious diseases including dengue fever and DHF is mandatory in Japan; according to a report from the National Institute of Infectious Diseases (NIID), about 10 adult-imported DHF cases are reported annually in Japan, corresponding to 5% of all imported dengue fever cases. 3 However, no pediatric case report has been published since 1989, 4 and only seven cases have been reported in Japanese medical meetings.
| CASE DESCRIPTION
In January, a 10-year-old Philippine boy was admitted to the hospital with a 4-day history of high fever, headache, and malaise, and a 2-day history of epistaxis and hematemesis. The patient lived near Manila and visited Japan to meet his family 4 days before he was brought to our hospital. He developed chills and malaise during his flight to Japan. There was an epidemic of dengue fever in the Philippines at that time, although the patient had no recollection of having been bitten by a mosquito. He had no previous history of dengue fever and had taken no protection against mosquito locally. Conjunctival hyperemia and redness of the tongue were noted, while joint pain, splenohepatomegaly, and rashes were not lasting 2-7 days, and a tendency to bleed, the patient was diagnosed with DHF. Intravascular volume repletion therapy (5 mL kg h −1 ) with Ringer's lactate was initiated, and the infusion rate was gradually reduced, following the WHO treatment guideline. 5 Although the platelet cell count decreased to 11 000/μL on day 2 following admission, it gradually increased, without the need for a blood transfusion. The patient was discharged on Day 4 following admission.
Reverse transcription-polymerase chain reaction analysis of the pa- Figure 3 ).
| DISCUSSION
Approximately 20%-30% of patients with DHF present with shock due to loss of intravascular volume. 6 Although the fatality rate of dengue shock syndrome is 40%-50%, it can be reduced to <1% with early detection and appropriate fluid management. 2 The World Health
Organization guidelines recommend attention to clinical warning signs for the development of severe dengue. 3 In this case, symptoms such as abdominal pain, hematemesis, a rising hematocrit, and thrombocytopenia and ascites around liver aided early diagnosis and enabled rapid implementation of fluid replacement therapy. A previous study demonstrated that platelet transfusion was ineffective in preventing bleeding in dengue infection, and that platelet recovery in patients was similar with or without platelet transfusion. 7 Furthermore, platelet transfusion may contribute to fluid overload and prolonged hospitalization. 8 Therefore, we did not perform a platelet transfusion for this patient.
DHF commonly occurs among patients with reinfection. This suggests that viral heterogeneity elicits an immunological response in patients with reinfection. 9 An interview with the patient did not reveal that a previous dengue viral infection had occurred, although a serological test suggested that the patient had a history of dengue viral infection. 2 The genome of dengue virus detected in the patient's plasma was similar to that of the virus that caused an outbreak in Samoa in 2001, which is geographically distant from the Philippines. Thus, we hypothesized that the heterogeneity of these viruses was associated with the development of DHF in this case.
When a dengue virus outbreak occurred in Tokyo, Japan in 2014, only one adult presented with DHF among 162 dengue-infected patients. 10 The following are possible reasons: Few patients who suffered from dengue fever in Japan had a previous dengue viral 
CONFLICT OF INTEREST
The authors have stated explicitly that there are no conflicts of interest in connection with this article. 
